Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around Jh on chromosome 14 and near a transcriptional unit on 18

[1]  B. Hecht,et al.  Use of novel chemical supplements in the establishment of three human malignant lymphoma cell lines (NU‐DHL‐1, NUDUL‐1, and NU‐AMB‐1) with chromosome 14 translocations , 1985, International journal of cancer.

[2]  F. Hecht,et al.  Histiocytic lymphoma cell lines: immunologic and cytogenetic studies. , 1985, Cancer genetics and cytogenetics.

[3]  P. Nowell,et al.  Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. , 1984, Science.

[4]  P. Nowell,et al.  Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. , 1984, Science.

[5]  R. Warnke,et al.  Monoclonality of lymphoproliferative lesions in cardiac-transplant recipients. Clonal analysis based on immunoglobulin-gene rearrangements. , 1984, The New England journal of medicine.

[6]  P. Leder,et al.  Activation and somatic mutation of the translocated c-myc gene in Burkitt lymphoma cells , 1984, Cell.

[7]  J. Winter,et al.  Phenotypic analysis of established diffuse histiocytic lymphoma cell lines utilizing monoclonal antibodies and cytochemical techniques , 1984 .

[8]  W. S. Hayward,et al.  Activation of a translocated human c-myc gene by an enhancer in the immunoglobulin heavy-chain locus , 1984, Nature.

[9]  T. Waldmann,et al.  Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms. , 1983, The New England journal of medicine.

[10]  P. Leder,et al.  Translocations among antibody genes in human cancer. , 1983, Science.

[11]  T. Waldmann,et al.  Lymphoid blast crises of chronic myelogenous leukemia represent stages in the development of B-cell precursors. , 1983, The New England journal of medicine.

[12]  J. Yunis.  The chromosomal basis of human neoplasia. , 1983, Science.

[13]  S. Tonegawa,et al.  A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene , 1983, Cell.

[14]  R. Perry.  Consequences of myc invasion of immunoglobulin loci: Facts and speculation , 1983, Cell.

[15]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[16]  S. Tonegawa.  Somatic generation of antibody diversity , 1983, Nature.

[17]  C. Croce,et al.  Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas. , 1983, Science.

[18]  M. Barbacid,et al.  Localization of the normal allele of T24 human bladder carcinoma oncogene to chromosome 11 , 1982, Nature.

[19]  P. Leder,et al.  Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[20]  R. R. Howe,et al.  Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma. , 1982, The New England journal of medicine.

[21]  T. Honjo,et al.  Structure of human immunoglobulin gamma genes: implications for evolution of a gene family , 1982, Cell.

[22]  J. Rowley,et al.  Identification of the constant chromosome regions involved in human hematologic malignant disease. , 1982, Science.

[23]  P. Leder,et al.  Chromosomal location of human kappa and lambda immunoglobulin light chain constant region genes , 1982, The Journal of experimental medicine.

[24]  Shows Tb,et al.  The 1981 catalogue of assigned human genetic markers and report of the nomenclature committee. Oslo Conference (1981): Sixth International Workshop on Human Gene Mapping. , 1982 .

[25]  Ulrich Siebenlist,et al.  Structure of the human immunoglobulin μ locus: Characterization of embryonic and rearranged J and D genes , 1981, Cell.

[26]  G. Klein.  The role of gene dosage and genetic transpositions in carcinogenesis , 1981, Nature.

[27]  Mark M. Davis,et al.  DNA sequences mediating class switching in alpha-immunoglobulins. , 1980, Science.

[28]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[29]  A. Sandberg,et al.  Establishment and characterization of human B‐lymphocytic lymphoma cell lines (balm‐3, ‐4 and ‐5): Intraclonal variation in the B‐cell differentiation stage , 1979, International journal of cancer.

[30]  J. Rowley,et al.  Chromosome abnormalities in poorly differentiated lymphocytic lymphoma. , 1979, Cancer research.

[31]  R. Levy,et al.  Biology of the human malignant lymphomas. IV. Functional characterization of ten diffuse histiocytic lymphoma cell lines , 1978, Cancer.

[32]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Oshimura,et al.  Cytogenetic and immunoglobulin markers of human leukemic B-cell lines. , 1977, Cancer research.

[34]  J. Waldron,et al.  Malignant lymphomas of follicular center cell origin in man. I. Immunologic studies. , 1975, Journal of the National Cancer Institute.

[35]  F. Ruddle,et al.  A REVIEW OF ENZYME POLYMORPHISM, LINKAGE AND ELECTROPHORETIC CONDITIONS FOR MOUSE AND SOMATIC CELL HYBRIDS IN STARCH GELS , 1973, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[36]  Henry Rappaport,et al.  Follicular lymphoma. A re‐evaluation of its position in the scheme of malignant lymphoma based on a survey of 253 cases , 1956 .